For patients with AF, these include use of edoxaban with concomitant antiplatelet agents, potential differences depending on the type of antiplatelet agents (ie, aspirin, P2Y12 inhibitors), and the effects of concomitant single or dual antiplatelet therapy. Here, P2RY12 is linked to atrial fibrillation.